Expertise in
4
conditions

Thomas R. Rimmele

Faculté De Médecine Lyon Est, 
Lyon, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
4
conditions
Faculté De Médecine Lyon Est, 
Lyon, FR 

Overview

Thomas Rimmele practices practicing medicine in Lyon, France.

Mr. Rimmele is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Sepsis, Metabolic Acidosis, Severe Acute Respiratory Syndrome (SARS), Pancreaticoduodenectomy, and Kidney Transplant.

He is actively involved in clinical research, co-authoring 224 peer reviewed articles and participating in 12 clinical trials.

Gender

Male

Locations

Faculté De Médecine Lyon Est, Lyon, 69008, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration
Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration
Enrollment Status: Recruiting
Publish Date: June 12, 2024
Intervention Type: Biological
REAnimation Low Immune Status Markers
REAnimation Low Immune Status Markers
Enrollment Status: Completed
Publish Date: December 19, 2025
Intervention Type: Biological
Study Phase: Not Applicable
Safety Profile of IntRAvenous Lidocaine Use in Coelioscopic Bariatric Surgery
Safety Profile of IntRAvenous Lidocaine Use in Coelioscopic Bariatric Surgery
Enrollment Status: Completed
Publish Date: December 19, 2025
Intervention Type: Biological, Drug
Study Phase: Phase 3
Creation of Arteriovenous Ante-brachial Fistula Under Axillary Block Versus Local Anesthesia : Impact on Early Complications
Creation of Arteriovenous Ante-brachial Fistula Under Axillary Block Versus Local Anesthesia : Impact on Early Complications
Enrollment Status: Completed
Publish Date: December 19, 2025
Intervention Type: Drug
Study Phase: Not Applicable
Open Label Randomized Controlled Trial of Ultraprotective Ventilation Without Extracorporeal Circulation in Patients With COVID 19 Pneumonia and Moderate to Severe ARDS
Open Label Randomized Controlled Trial of Ultraprotective Ventilation Without Extracorporeal Circulation in Patients With COVID 19 Pneumonia and Moderate to Severe ARDS
Enrollment Status: Completed
Publish Date: December 10, 2025
Intervention Type: Other
Study Phase: Not Applicable
Assessment of Therapeutic Plasma Exchange to Improve Respiratory Function by Alleviating Cytokine Storm During Severe Covid-19 Infections Randomised Open-label Controlled Trial
Assessment of Therapeutic Plasma Exchange to Improve Respiratory Function by Alleviating Cytokine Storm During Severe Covid-19 Infections Randomised Open-label Controlled Trial
Enrollment Status: Completed
Publish Date: September 03, 2025
Intervention Type: Other
Study Phase: Not Applicable
A Double-Blind, Randomized, Placebo-controlled Multicenter Trial of GRanulocyte-Macrophage Colony-stimulating Factor Administration to Decrease ICU Acquired Infections in Sepsis-induced ImmunoDepression
A Double-Blind, Randomized, Placebo-controlled Multicenter Trial of GRanulocyte-Macrophage Colony-stimulating Factor Administration to Decrease ICU Acquired Infections in Sepsis-induced ImmunoDepression
Enrollment Status: Completed
Publish Date: September 03, 2025
Intervention Type: Drug
Study Phase: Phase 3
Endotoxins and Cytokines Removal During Continuous Hemofiltration With oXiris™
Endotoxins and Cytokines Removal During Continuous Hemofiltration With oXiris™
Enrollment Status: Completed
Publish Date: December 05, 2023
Intervention Type: Biological, Device
Study Phase: Not Applicable
Validation of the Efficiency of Molecules Reproposed on the Basis of Their Cellular Transcriptomic Signature, Antagonist of the Signature Determined in Infection Due to Virus Influenza A.
Validation of the Efficiency of Molecules Reproposed on the Basis of Their Cellular Transcriptomic Signature, Antagonist of the Signature Determined in Infection Due to Virus Influenza A.
Enrollment Status: Terminated
Publish Date: February 06, 2023
Intervention Type: Drug
Study Phase: Phase 2
The OPTI-AGED Study : Influence of a Multi-parametric Optimization Strategy for General Anesthesia on Postoperative Morbidity and Mortality in Elderly Patients. A Randomized, Multicentre, Prospective Controlled Study
The OPTI-AGED Study : Influence of a Multi-parametric Optimization Strategy for General Anesthesia on Postoperative Morbidity and Mortality in Elderly Patients. A Randomized, Multicentre, Prospective Controlled Study
Enrollment Status: Completed
Publish Date: August 26, 2021
Intervention Type: Procedure
Study Phase: Not Applicable
View 9 Less Clinical Trials

224 Total Publications

Albumin-corrected tCa/iCa ratio: are we still diagnosing citrate accumulation or predicting mortality?
Albumin-corrected tCa/iCa ratio: are we still diagnosing citrate accumulation or predicting mortality?
Journal: Critical care (London, England)
Published: March 31, 2026

Frequently Asked Questions about Thomas R. Rimmele

Is Thomas R. Rimmele a top-rated expert for Sepsis?

MediFind is an objective health platform that identifies experts based on real-world data. Thomas R. Rimmele is classified as an Elite expert for Sepsis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Thomas R. Rimmele participate in research or clinical trials?

Yes. Thomas R. Rimmele has published 224 articles and abstracts on conditions like Sepsis. You can view a list of Thomas R. Rimmele's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Rimmele's expertise for a condition
ConditionClose
    View All 25 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile